“In a (brand new) study…focused on the medical products industry – which includes medical devices, pharmaceuticals and biologics – a group of researchers found that…firms with female directors announced (life-threatening) high-severity product recalls 28 days sooner.” The Study’s Executive Summary, April 20, 2020… So, before you get that stent put in or new COVID-19 treatment or vaccine, find out how many women are on the board. It could literally save your life, according to a new first-of-its-kind study by a group of researchers from four top universities, which found that public medical products companies with more women on their boards recalled defective more often and much sooner that all-male or one-woman boards. Listen to one of the study’s co-authors, Dr. Corinne Post of Lehigh University, in this important interview on Green Connections Radio podcast with host Joan Michelson.
